Cancer Gene Therapy
Data on cancer gene therapy discussed by investigators at University of Birmingham, Institute for Biomedical Research
Published in Cancer Law Weekly, September 26th, 2009
A report, 'Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane,' is newly published data in British Journal of Cancer. According to a study from Edgbaston, the United Kingdom, "Considerable interest lies in the identification of novel anti-angiogenic compounds for cancer therapy. We have investigated whether dexrazoxane has anti-angiogenic properties and if so, the mechanism of the inhibition."
"The phenotypic effects of dexrazoxane on endothelial cell behaviour was investigated both in vitro using human umbilical vein endothelial cells (HUVECs) in cell proliferation, migration, cell cycle and aortic ring assays; and in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2009-09-26)
More Articles from Cancer Law Weekly
- American Society for Nanomedicine
Newly Formed American Society for Nanomedicine (ASNM) to Hold First Conference (www.amsocnanomed.org) - Biotechnology
Study documents growth, benefits of collaboration between developed and developing country medical science firms - Brain Cancer
Scientists at Seoul National University, Medical Department release new data on brain cancer - Breast Cancer
Research in the area of breast cancer reported from R. Divella and colleagues - Business News
Acumen(R) eX3: viable alternative for FMAT analysis - Cancer Gene Therapy
Scientists at Gene Therapy Center describe research in cancer gene therapy - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
